TELA Bio (TELA) Competitors $2.90 -0.01 (-0.34%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TELA vs. APYX, ICAD, CODX, PYPD, TTOO, CATX, TCMD, ZIMV, RCEL, and SMLRShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Apyx Medical (APYX), iCAD (ICAD), Co-Diagnostics (CODX), PolyPid (PYPD), T2 Biosystems (TTOO), Perspective Therapeutics (CATX), Tactile Systems Technology (TCMD), ZimVie (ZIMV), AVITA Medical (RCEL), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. TELA Bio vs. Apyx Medical iCAD Co-Diagnostics PolyPid T2 Biosystems Perspective Therapeutics Tactile Systems Technology ZimVie AVITA Medical Semler Scientific Apyx Medical (NASDAQ:APYX) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, community ranking, valuation, earnings and profitability. Do institutionals & insiders have more ownership in APYX or TELA? 55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 94.4% of TELA Bio shares are held by institutional investors. 16.8% of Apyx Medical shares are held by company insiders. Comparatively, 6.0% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better valuation & earnings, APYX or TELA? Apyx Medical has higher earnings, but lower revenue than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$52.35M1.01-$18.71M-$0.83-1.69TELA Bio$58.45M1.95-$46.66M-$1.69-1.72 Which has more risk and volatility, APYX or TELA? Apyx Medical has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Is APYX or TELA more profitable? Apyx Medical has a net margin of -58.59% compared to TELA Bio's net margin of -60.49%. Apyx Medical's return on equity of -137.98% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-58.59% -137.98% -36.74% TELA Bio -60.49%-556.18%-63.13% Do analysts rate APYX or TELA? TELA Bio has a consensus target price of $9.25, indicating a potential upside of 218.97%. Given TELA Bio's stronger consensus rating and higher probable upside, analysts plainly believe TELA Bio is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67TELA Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor APYX or TELA? Apyx Medical received 19 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.68% of users gave TELA Bio an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformApyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% TELA BioOutperform Votes5974.68% Underperform Votes2025.32% Does the media refer more to APYX or TELA? In the previous week, TELA Bio had 2 more articles in the media than Apyx Medical. MarketBeat recorded 2 mentions for TELA Bio and 0 mentions for Apyx Medical. TELA Bio's average media sentiment score of 0.51 beat Apyx Medical's score of 0.00 indicating that TELA Bio is being referred to more favorably in the news media. Company Overall Sentiment Apyx Medical Neutral TELA Bio Positive SummaryApyx Medical beats TELA Bio on 10 of the 19 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$114.62M$4.47B$5.07B$8.90BDividend YieldN/A36.79%4.99%4.07%P/E Ratio-1.7213.2787.8613.46Price / Sales1.9544.831,228.8287.66Price / CashN/A52.2739.5136.27Price / Book-18.135.776.946.30Net Income-$46.66M$13.76M$119.12M$225.93M7 Day Performance-4.61%-1.10%-1.84%-1.32%1 Month Performance15.54%0.56%-3.65%0.60%1 Year Performance-40.33%50.90%31.64%26.23% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio3.7058 of 5 stars$2.90-0.3%$9.25+219.0%-40.5%$114.62M$58.45M-1.72120APYXApyx Medical1.4379 of 5 stars$1.40+9.4%N/A-39.1%$48.18M$52.35M0.00270ICADiCAD0.5189 of 5 stars$1.55-1.3%N/A+16.2%$41.40M$17.32M-11.8867Analyst UpgradeCODXCo-Diagnostics4.3727 of 5 stars$1.04-2.8%$1.50+44.2%-27.8%$34.17M$6.81M0.00100Short Interest ↓Gap DownPYPDPolyPid2.8681 of 5 stars$3.49-3.1%$12.00+243.8%-14.3%$17.27MN/A0.0080Positive NewsHigh Trading VolumeTTOOT2 Biosystems2.4481 of 5 stars$0.46-4.2%$5.00+982.7%-88.3%$10.16M$7.19M0.00180CATXPerspective Therapeutics2.7597 of 5 stars$6.16-9.1%$21.57+250.2%N/A$458.24M$1.43M0.00116Analyst RevisionTCMDTactile Systems Technology3.7846 of 5 stars$15.56-1.3%$23.00+47.8%+23.1%$378.43M$274.42M23.94980ZIMVZimVie2.5824 of 5 stars$13.49+2.4%$18.33+35.9%+49.2%$363.48M$457.43M0.002,600RCELAVITA Medical1.4051 of 5 stars$13.05+0.7%$16.50+26.4%+4.1%$339.78M$50.14M0.00130SMLRSemler Scientific1.0709 of 5 stars$59.27+27.9%N/A+60.6%$336.72M$68.18M28.9192Gap UpHigh Trading Volume Related Companies and Tools Related Companies Apyx Medical Competitors iCAD Competitors Co-Diagnostics Competitors PolyPid Competitors T2 Biosystems Competitors Perspective Therapeutics Competitors Tactile Systems Technology Competitors ZimVie Competitors AVITA Medical Competitors Semler Scientific Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TELA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TELA Stock Alerts